{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:54Z","timestamp":1787020914862,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C1251"],"award-info":[{"award-number":["HI14C1251"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13195-019-0499-7","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T14:44:51Z","timestamp":1557499491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Blood amyloid-\u03b2 oligomerization associated with neurodegeneration of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Young Chul","family":"Youn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeewon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Min","family":"Pyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Hyang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo A.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1126\/science.2218531","volume":"250","author":"BA Yankner","year":"1990","unstructured":"Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 1990;250:279\u201382.","journal-title":"Science"},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM. Alzheimer\u2019s disease. Eur J Neurol. 2018;25:59\u201370.","journal-title":"Eur J Neurol"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.1073\/pnas.96.20.11049","volume":"96","author":"S Sinha","year":"1999","unstructured":"Sinha S, Lieberburg I. Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci U S A. 1999;96:11049\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A. 2009;106:4012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8:101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1212\/WNL.0000000000001231","volume":"84","author":"LG Apostolova","year":"2015","unstructured":"Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, et al. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 2015;84:729\u201337.","journal-title":"Neurology"},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2012-120058","volume":"30","author":"AD Watt","year":"2012","unstructured":"Watt AD, Perez KA, Rembach AR, Masters CL, Villemagne VL, Barnham KJ. Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. J Alzheimers Dis. 2012;30:323\u201336.","journal-title":"J Alzheimers Dis"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-017-0310-6","volume":"9","author":"SSA An","year":"2017","unstructured":"An SSA, Lee BS, Yu JS, Lim K, Kim GJ, Lee R, et al. Dynamic changes of oligomeric amyloid beta levels in plasma induced by spiked synthetic Abeta42. Alzheimers Res Ther. 2017;9:86.","journal-title":"Alzheimers Res Ther"},{"key":"499_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-017-0324-0","volume":"9","author":"MJ Wang","year":"2017","unstructured":"Wang MJ, Yi S, Han JY, Park SY, Jang JW, Chun IK, et al. Oligomeric forms of amyloid-beta protein in plasma as a potential blood-based biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9:98.","journal-title":"Alzheimers Res Ther"},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bbrc.2010.01.053","volume":"392","author":"SS An","year":"2010","unstructured":"An SS, Lim KT, Oh HJ, Lee BS, Zukic E, Ju YR, et al. Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection System. Biochem Biophys Res Commun. 2010;392:505\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"499_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/nnm.14.101","volume":"10","author":"K Lim","year":"2015","unstructured":"Lim K, Kim SY, Lee B, Segarra C, Kang S, Ju Y, et al. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep. Int J Nanomedicine. 2015;10:241\u201350.","journal-title":"Int J Nanomedicine"},{"key":"499_CR14","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1006\/nimg.2001.0961","volume":"14","author":"J Ashburner","year":"2001","unstructured":"Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage. 2001;14:1238\u201343.","journal-title":"Neuroimage"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1006\/nimg.2000.0582","volume":"11","author":"J Ashburner","year":"2000","unstructured":"Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805\u201321.","journal-title":"Neuroimage"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1212\/01.wnl.0000219625.77625.aa","volume":"66","author":"S Xie","year":"2006","unstructured":"Xie S, Xiao JX, Gong GL, Zang YF, Wang YH, Wu HK, et al. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology. 2006;66:1845\u20139.","journal-title":"Neurology"},{"key":"499_CR17","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jocn.2011.11.041","volume":"19","author":"SY Ha","year":"2012","unstructured":"Ha SY, Youn YC, Kim S, Hsiung GY, Ahn SW, Shin HW, et al. A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer\u2019s disease with white matter hyperintensities. J Clin Neurosci. 2012;19:1506\u201310.","journal-title":"J Clin Neurosci"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/ggi.12464","volume":"16","author":"SH Choi","year":"2016","unstructured":"Choi SH, Park MH. Three screening methods for cognitive dysfunction using the Mini-Mental State Examination and Korean Dementia Screening Questionnaire. Geriatr Gerontol Int. 2016;16:252\u20138.","journal-title":"Geriatr Gerontol Int"},{"issue":"3","key":"499_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.archger.2007.08.012","volume":"47","author":"Changsu Han","year":"2008","unstructured":"Han C, Jo SA, Jo I, Kim E, Park MH, Kang Y. An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: demographic influence and population-based norms (the AGE study). Arch Gerontol Geriatr. 2008;47(3):302-10.","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"HJ Ahn","year":"2010","unstructured":"Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci. 2010;25:1071\u20136.","journal-title":"J Korean Med Sci"},{"key":"499_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734\u201346.","journal-title":"Lancet Neurol"},{"key":"499_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.neuroimage.2011.10.025","volume":"62","author":"J Ashburner","year":"2012","unstructured":"Ashburner J. SPM: a history. Neuroimage. 2012;62:791\u2013800.","journal-title":"Neuroimage"},{"key":"499_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nprot.2015.014","volume":"10","author":"F Kurth","year":"2015","unstructured":"Kurth F, Gaser C, Luders E. A 12-step user guide for analyzing voxel-wise gray matter asymmetries in statistical parametric mapping (SPM). Nat Protoc. 2015;10:293\u2013304.","journal-title":"Nat Protoc"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","volume":"26","author":"J Ashburner","year":"2005","unstructured":"Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839\u201351.","journal-title":"Neuroimage"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neuroimage.2008.12.037","volume":"46","author":"A Klein","year":"2009","unstructured":"Klein A, Andersson J, Ardekani BA, Ashburner J, Avants B, Chiang MC, et al. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage. 2009;46:786\u2013802.","journal-title":"Neuroimage"},{"key":"499_CR26","first-page":"505","volume":"69","author":"K Nemoto","year":"2017","unstructured":"Nemoto K. Understanding voxel-based morphometry. Brain Nerve. 2017;69:505\u201311.","journal-title":"Brain Nerve"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cercor\/11.1.1","volume":"11","author":"PM Thompson","year":"2001","unstructured":"Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, et al. Cortical change in Alzheimer\u2019s disease detected with a disease-specific population-based brain atlas. Cereb Cortex. 2001;11:1\u201316.","journal-title":"Cereb Cortex"},{"key":"499_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(01)05408-3","volume":"358","author":"NC Fox","year":"2001","unstructured":"Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN. Imaging of onset and progression of Alzheimer\u2019s disease with voxel-compression mapping of serial magnetic resonance images. Lancet. 2001;358:201\u20135.","journal-title":"Lancet"},{"key":"499_CR29","unstructured":"Bu XL, Xiang Y, Jin WS, Wang J, Shen LL, Huang ZL, et al. Blood-derived amyloid-beta protein induces Alzheimer's disease pathologies. Mol Psychiatry. 2018;23(9):1-9."},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol. 2018;14:639\u201352.","journal-title":"Nat Rev Neurol"},{"key":"499_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O'Bryant","year":"2017","unstructured":"O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, et al. Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement. 2017;13:45\u201358.","journal-title":"Alzheimers Dement"},{"key":"499_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40291-016-0241-0","volume":"21","author":"A Keshavan","year":"2017","unstructured":"Keshavan A, Heslegrave A, Zetterberg H, Schott JM. Blood biomarkers for Alzheimer\u2019s disease: much promise, cautious progress. Mol Diagn Ther. 2017;21:13\u201322.","journal-title":"Mol Diagn Ther"},{"key":"499_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.dadm.2017.07.004","volume":"8","author":"N Fandos","year":"2017","unstructured":"Fandos N, Perez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, et al. Plasma amyloid beta 42\/40 ratios as biomarkers for amyloid beta cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst). 2017;8:179\u201387.","journal-title":"Alzheimers Dement (Amst)"},{"key":"499_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and Down syndrome. Mol Neurodegener. 2017;12:63.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"499_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.25334","volume":"84","author":"IMW Verberk","year":"2018","unstructured":"Verberk IMW, Slot RE, Verfaillie SCJ, Heijst H, Prins ND, van Berckel BNM, et al. Plasma amyloid as prescreener for the earliest Alzheimer pathological changes. Ann Neurol. 2018;84(5):648\u201358.","journal-title":"Ann Neurol"},{"key":"499_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1021\/cn200028j","volume":"2","author":"CC Yang","year":"2011","unstructured":"Yang CC, Yang SY, Chieh JJ, Horng HE, Hong CY, Yang HC, et al. Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer\u2019s disease in vitro. ACS Chem Neurosci. 2011;2:500\u20135.","journal-title":"ACS Chem Neurosci"},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fnagi.2017.00226","volume":"9","author":"LF Lue","year":"2017","unstructured":"Lue LF, Sabbagh MN, Chiu MJ, Jing N, Snyder NL, Schmitz C, et al. Plasma levels of Abeta42 and tau identified probable Alzheimer\u2019s dementia: findings in two cohorts. Front Aging Neurosci. 2017;9:226.","journal-title":"Front Aging Neurosci"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/jnnp.72.6.742","volume":"72","author":"M Bozzali","year":"2002","unstructured":"Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, et al. White matter damage in Alzheimer\u2019s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2002;72:742\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"499_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","volume":"134","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, et al. Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol. 2017;134:459\u201373.","journal-title":"Acta Neuropathol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0499-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0499-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0499-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T06:00:34Z","timestamp":1607752834000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0499-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0499-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by institutional review board of Seoul National University Bundang Hospital and Chung-Ang University Hospital [B-0905-075-003, B-1202-145-003, C2012048(743), C2013142(1102)]. Written informed consent was obtained from all patients who participated in this study or from their caregivers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented to publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"40"}}